144 related articles for article (PubMed ID: 2496903)
1. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
Molloi S; Mazess R; Bendsen H; Wilson M
Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
[TBL] [Abstract][Full Text] [Related]
2. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
6. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
Smith ML; Martin W; Fogelman I; Bessent RG
J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
[TBL] [Abstract][Full Text] [Related]
7. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
[TBL] [Abstract][Full Text] [Related]
8. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
10. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
11. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
[TBL] [Abstract][Full Text] [Related]
12. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
Seto H; Kakishita M; Futatsuya R
Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
15. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
17. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.
Hyldstrup L; Mogensen N; Jensen GF; McNair P; Transbøl I
Scand J Clin Lab Invest; 1984 Apr; 44(2):105-9. PubMed ID: 6426035
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
[TBL] [Abstract][Full Text] [Related]
19. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies].
Kapitola J; Jahoda I; Kobos L; Vilimovská D
Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622
[No Abstract] [Full Text] [Related]
20. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]